End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Global Clinical Trials Review, H2, 2017

2017-08-11
Price :
Published : Aug-2017
No. of Pages : 374
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
GlobalData Clinical Trials Report Coverage 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Five Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by G7 Countries: Proportion of End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) to Genito Urinary System And Sex Hormones Clinical Trials 16
Clinical Trials by Phase in G7 Countries 18
Clinical Trials in G7 Countries by Trial Status 19
Clinical Trials by E7 Countries: Proportion of End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) to Genito Urinary System And Sex Hormones Clinical Trials 20
Clinical Trials by Phase in E7 Countries 22
Clinical Trials in E7 Countries by Trial Status 23
Clinical Trials by Phase 24
In Progress Trials by Phase 25
Clinical Trials by Trial Status 26
Clinical Trials by End Point Status 27
Subjects Recruited Over a Period of Time 28
Clinical Trials by Sponsor Type 29
Prominent Sponsors 30
Top Companies Participating in End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials 32
Prominent Drugs 34
Clinical Trial Profile Snapshots 35
Appendix 372
Abbreviations 372
Definitions 372
Research Methodology 373
Secondary Research 373
About GlobalData 374
Contact Us 374
Source 374

List of Tables
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics, Global, Clinical Trials by Region, 2017* 7
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 9
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 10
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 11
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 12
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials, North America, Top Countries, 2017* 13
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2017* 14
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2017* 15
Proportion of End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) to Genito Urinary System And Sex Hormones Clinical Trials, G7 Countries (%), 2017* 17
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 18
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 19
Proportion of End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) to Genito Urinary System And Sex Hormones Clinical Trials, E7 Countries (%), 2017* 21
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 22
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 23
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics, Global, Clinical Trials by Phase, 2017* 24
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 25
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics, Global, Clinical Trials by Trial Status, 2017* 26
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials, Global, by End Point Status, 2017* 27
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 28
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 29
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 31
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 33
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 34

List of Figures
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics, Global, Clinical Trials by Region (%), 2017* 7
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 10
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017* 11
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 12
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 13
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2017* 14
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2017* 15
Proportion of End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) to Genito Urinary System And Sex Hormones Clinical Trials, G7 Countries (%), 2017* 16
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 18
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 19
Proportion of End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) to Genito Urinary System And Sex Hormones Clinical Trials, E7 Countries (%), 2017* 20
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 22
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 23
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics, Global, Clinical Trials by Phase (%), 2017* 24
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 25
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics, Global, Clinical Trials by Trial Status, 2017* 26
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials, Global, by End Point Status, 2017* 27
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 28
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 29
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 30
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 32
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 34
GlobalData Methodology 373
Filed in: Pharmaceutical, Pharmaceuticals and Healthcare
Publisher : GlobalData